http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004219104-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-475 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475 |
| filingDate | 2003-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e6031a3ad097ef17bd475f1b23861b7 |
| publicationDate | 2004-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2004219104-A1 |
| titleOfInvention | Methods for treatment of tumors |
| abstract | The invention provides methods useful for the treatment of tumors and other diseases. The methods of the invention involve the administration of a composition containing two conjugates; the first conjugate containing human vascular endothelial growth factor (VEGF) and radiolabeled human transferrin and the second conjugate containing human epidermal growth factor (EGF) and radiolabeled human transferrin to a host having a tumor. |
| priorityDate | 2003-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 211.